HPLC Purification of Peptides

Overview

High-performance liquid chromatography is the workhorse of peptide purification. Raw peptide — whether produced by solid-phase peptide synthesis (SPPS) or recombinant expression — is a mixture of target plus deletion sequences, truncations, oxidation products, and other byproducts. Preparative HPLC separates the target from these contaminants to pharmaceutical- or research-grade purity, typically greater than 95%.

A review of analytical HPLC principles is given in the HPLC glossary entry; this article focuses on the practical workflow for purifying peptides.

Column Chemistry

Reversed-phase (RP)

The dominant mode for peptides. Stationary phase is a hydrophobic alkyl-bonded silica — typically C18, sometimes C8 or C4 for larger/more hydrophobic peptides. Mobile phase is aqueous with organic modifier (acetonitrile most common; methanol occasionally).

Column selection:

• C18 (octadecyl) — standard for most peptides
• C8 (octyl) — for hydrophobic peptides that retain too strongly on C18
• C4 (butyl) — for very hydrophobic peptides, lipopeptides, proteins
• Phenyl — alternative selectivity for aromatic-rich peptides
• HILIC — hydrophilic interaction for very polar peptides

Ion exchange

Less common, but useful for very hydrophilic or highly charged peptides that lack sufficient hydrophobicity for RP.

Size exclusion

Useful as a polishing step for removing aggregates, not for primary purification.

Mobile Phase

Acidic modifiers

• Trifluoroacetic acid (TFA) — 0.1% in both A and B; excellent peak shape, masks zwitterion effects, but suppresses MS signal
• Formic acid — 0.1% for MS-compatible work
• Phosphoric acid — sharp peaks, not MS-compatible, not suitable for downstream biology

Buffered systems

Ammonium acetate (pH ~6) or ammonium bicarbonate (pH ~8) for peptides sensitive to acid or when a neutral pH purification is preferred.

Organic modifier

• Acetonitrile — standard; low UV cutoff, excellent for detection at 214 nm
• Methanol — higher viscosity, backpressure increases
• Isopropanol — stronger elution, useful for hydrophobic peptides

Gradient Design

Typical analytical conditions:

• Start: 95% A / 5% B
• End: 40% A / 60% B
• Gradient length: 20–30 min
• Flow: 1 mL/min on 4.6 mm ID column

Scale-up to preparative:

• Flow scales with column cross-sectional area (21 mm ID ≈ 20 mL/min)
• Load capacity scales with stationary phase mass (typically 1–10 mg peptide per g stationary phase)
• Gradient slope should be shallower around target elution for best resolution

Always scout with an analytical gradient (fast, broad) to find target elution, then develop a narrower focused gradient around that point for the preparative run.

Detection

• UV absorbance at 214 nm — monitors peptide bonds; universal for all peptides
• UV absorbance at 280 nm — detects aromatic residues (Trp, Tyr)
• Fluorescence — if peptide labeling includes a fluorophore
• Inline MS (LC-MS) — confirms identity of each peak during purification
• Evaporative light scattering — for peptides without chromophores

Sample Preparation

Before loading:

1. Dissolve crude peptide in minimal solvent — usually starting mobile phase composition
2. Filter or centrifuge to remove insoluble matter
3. Check peptide solubility; add trace organic or DMSO if needed
4. Watch for peptide aggregation — very hydrophobic peptides may require denaturing additives (6 M guanidine, 8 M urea) that are later removed

Loading

• Volume: as small as possible — ideally 0.5–2% of column volume
• Mass: within column capacity to avoid overloading and peak broadening
• Concentration: high enough to avoid dilution of product streams

Overloaded columns show fronting, tailing, or peak splitting; underloaded columns waste time and consumables.

Fraction Collection

• Collect small fractions (0.5–2 column volumes each) across the target peak
• Track each fraction by analytical HPLC and mass spec analysis
• Pool fractions that meet purity and identity criteria
• Beware of leading/trailing impurities that co-elute close to the main peak

Post-Purification Handling

Desalting and counter-ion exchange

TFA leaves trifluoroacetate counter-ions on basic residues. For biology, exchange to acetate (preferred) or hydrochloride:

• Repeat RP-HPLC with 0.1% acetic acid instead of TFA
• Ion exchange chromatography
• Lyophilization from dilute acetic acid solution (partial exchange)

Concentration

• Rotary evaporation for small volumes
• Centrifugal evaporator (SpeedVac)
• Lyophilization is standard for final product

Storage

• Lyophilized peptide stored at -20°C or -80°C
• Reconstituted solutions per peptide storage guidelines
• Watch for peptide degradation during storage

Quality Criteria

After purification:

• Purity >95% by analytical HPLC (area %)
• Identity confirmed by mass spec analysis
• No single impurity >1% (tighter thresholds for clinical material)
• Counter-ion and solvent content within specification
• Endotoxin testing and sterility testing if intended for biology

See the dedicated article on quality assessment for a comprehensive checklist.

Troubleshooting

• Tailing peaks — check column condition, consider TFA instead of formic acid
• Target co-elutes with impurity — try C4 or phenyl column, different organic modifier, or different pH buffer
• Poor recovery — peptide may be sticking to tubing or filters; use low-bind plastics and minimize transfer steps
• Precipitation on column — check peptide aggregation, increase temperature, add chaotropes, dilute loading

Summary

HPLC purification converts crude peptide material into pure, characterized product ready for biological or therapeutic use. A purification campaign should define the column, mobile phase, gradient, and detection before scaling, and should be paired with rigorous QC via analytical HPLC, mass spectrometry, and downstream assays.